BioCryst Pharmaceuticals
BCRX
#4635
Rank
S$2.80 B
Marketcap
S$11.19
Share price
-2.77%
Change (1 day)
8.70%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): S$0.34 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are S$0.87 Billion. , an increase over its 2024 earnings that were of -S$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 S$0.34 B-407.51%
2024 -S$0.12 Billion-61.56%
2023 -S$0.29 Billion-7.43%
2022 -S$0.32 Billion34.42%
2021 -S$0.24 Billion-0.55%
2020 -S$0.24 Billion67.88%
2019 -S$0.14 Billion7.55%
2018 -S$0.13 Billion53.92%
2017 -S$84.01 Million19.29%
2016 -S$70.42 Million28.19%
2015 -S$54.94 Million-4.8%
2014 -S$57.71 Million50.09%
2013 -S$38.45 Million-23.29%
2012 -S$50.13 Million-26.19%
2011 -S$67.91 Million54.78%
2010 -S$43.88 Million150.1%
2009 -S$17.55 Million-49.43%
2008 -S$34.69 Million14.07%
2007 -S$30.41 Million-49.31%
2006 -S$60 Million72.87%
2005 -S$34.71 Million22.08%
2004 -S$28.43 Million75.3%
2003 -S$16.22 Million-25.36%
2002 -S$21.73 Million225.05%
2001 -S$6.69 Million-56.6%
2000 -S$15.41 Million50.63%
1999 -S$10.23 Million38.05%
1998 -S$7.41 Million-52.46%
1997 -S$15.58 Million58.44%
1996 -S$9.84 Million-14.44%
1995 -S$11.5 Million28.57%
1994 -S$8.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
S$12.51 B 3,563.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$12.63 B 3,600.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-S$0.33 Billion-194.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$0.10 B-68.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$0.47 B 40.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.37 Billion-207.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-S$10.38 Million-103.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$31.63 Million-109.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-38.18%๐Ÿ‡บ๐Ÿ‡ธ USA